Drug Shortage Report for REMIFENTANIL HYDROCHLORIDE FOR INJECTION

Last updated on 2022-07-27 History
Report ID 153969
Drug Identification Number 02366479
Brand name REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Common or Proper name REMIFENTANIL HYDROCHLORIDE FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) REMIFENTANIL
Strength(s) 2MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code N01AH
ATC description ANESTHETICS, GENERAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2022-01-21
Estimated end date Unknown
Actual end date 2022-07-26
Shortage status Resolved
Updated date 2022-07-27
Company comments Product is on allocation at 100% at McKesson.
Health Canada comments
Tier 3 Status Yes
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2022-07-27 English Compare
v9 2022-07-26 French Compare
v8 2022-07-26 English Compare
v7 2022-05-27 French Compare
v6 2022-05-27 English Compare
v5 2022-03-03 English Compare
v4 2022-02-22 French Compare
v3 2022-02-22 English Compare
v2 2022-02-01 French Compare
v1 2022-02-01 English Compare

Showing 1 to 10 of 10